SPONSOR
Fujian Medical University Union Hospital
Total Trials
4
Recruiting
4
Phases
N/A
Fujian Medical University Union Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Melasma, Esophageal Squamous Cell Carcinoma (ESCC), AML, Adult.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fujian Medical University Union Hospital
How many clinical trials has Fujian Medical University Union Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Fujian Medical University Union Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Melasma, Esophageal Squamous Cell Carcinoma (ESCC), AML. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fujian Medical University Union Hospital research focus on?
Fujian Medical University Union Hospital clinical trials span Melasma, Esophageal Squamous Cell Carcinoma (ESCC), AML, Adult. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Fujian Medical University Union Hospital clinical trial?
To participate in a Fujian Medical University Union Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fujian Medical University Union Hospital trials with current recruitment status updated daily.
Clinical Trials by Fujian Medical University Union Hospital
NCT06221787
Recruiting
Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration
Melasma
NCT06710665
Recruiting
Tumor Regression Grade As Predictor of Adjuvant Therapy
Esophageal Squamous Cell Carcinoma (ESCC)
NCT07587944
Recruiting
Biomarkers in Bone Marrow Supernatant for Predicting AML Chemosensitivity
AML
NCT07163728
Recruiting
Leptin: A Marker for AML Chemo-Sensitivity
AML
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology